Developmental epigenetic origins of Group 3 and 4 medulloblastoma

第 3 组和第 4 组髓母细胞瘤的发育表观遗传起源

• 批准号: 473363
• 负责人: Pai Shraddha
• 金额: $ 7.29万
• 依托单位: Ontario Institute for Cancer Research (Toronto, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-09-01 至 2023-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=473363&lang=en
• 关键词: Brain Cancer; Epigenomics; Genomics

Medulloblastoma accounts for ~20% of childhood brain cancers. Current treatment involves surgical removal, followed by chemotherapy or radiation therapy. Survivors often experience learning and memory problems because of these harsh treatments. Therefore

髓母细胞瘤约占儿童脑癌的20%。目前的治疗包括手术切除，然后是化疗或放疗。由于这些严酷的治疗，幸存者经常经历学习和记忆问题。因此